Adult mesenchymal stem cells (MSCs) are widely regarded as a plastic-adherent cell population, which has self-renewal capacity and can be differentiated into osteogenic, chondrogenic, adipogenic, and other lineages [1, 2]. In addition, MSCs showed low immunogenicity and strong immunomodulation potential [3]. MSCs can be isolated and identified from many tissues, such as bone marrow, adipose tissue, dermal tissue, intervertebral disc, amniotic fluid, various dental tissues, human placenta, and cord blood [4]. MSCs have functions in the maintenance of tissue homeostasis and have potential applications in regenerative medicine. These cells have been successfully employed in clinical applications, such as cartilage and bone repair, skin wound healing, neuronal regeneration, heart regeneration, and immune disorder treatment including treatment of graft versus host disease (GvHD) due to their abilities of homing, multilineage differentiation, and immunomodulation [5]. However, the natural characteristics and function of MSCs from different tissues are heterogeneous [6]; therefore, deeper understanding of the differences of MSCs derived from various sources would help us to make better choices for disease treatment. Furthermore, the culture expansion in vitro has been reported to attenuate the homing ability of MSCs [7], which suggests that MSCs may lose some of their natural characteristics after expansion in vitro. Hence, novel strategies for maintaining, and even promoting, the biological activities and therapeutic capabilities of MSCs are really needed.
In this special issue, we have invited state-of-the-art research contributions on MSC characteristics, functions, and applications. After a rigorous review process, we selected seven papers to appear here. Y. Ma et al. isolated and identified MSC-like cells expressing alpha-smooth muscle actin (-SMA) from adult human sweat glands (ahSGs) for the first time. These cells are located in the basal myoepithelial areas of the secretory portion of the solenoid bulb. This report demonstrated that there are tissue-specific MSCs in ahSGs that may contribute to wound repair and sweat gland regeneration. C.A.F. Mananares et al. found that yolk sac-derived MSCs could form tubular structures in vitro, which suggested the possible formation of blood capillaries in vitro by MSCs. T. Khatlani et al. have assessed the biological activities of MSCs from the decidua basalis (DBMSCs) after exposing DBMSCs to hydrogen peroxide (H2O2). The results in their study indicated that DBMSCs could resist an oxidative stress environment and gain beneficial effects from this toxic environment on their ability to repair injured tissues. J. Zhan et al. reported that fasudil, a potent rho kinase inhibitor, significantly enhanced the migration ability of bone marrow MSCs via activation of the MAPK signaling pathway, promoting MSC homing to the spinal cord injury site. This study showed that combination of MSC transplantation and fasudil administration might have beneficial effects in therapy after central nervous system trauma. Y. Nakashima et al. performed a protein expression analysis by liquid chromatography with tandem mass spectrometry (LC-MS/MS) to investigate the influences of cell stress resulting from passage on protein expression in adipose-derived MSCs (AT-MSCs). They found that AT-MSCs retained their cell properties after three passages but showed a decreased protein expression. In addition, there are two reviews in this special issue. A. Tomokiyo et al. reviewed the current understanding of the features and functions of MSCs in periodontal ligament (PDL) tissue and discussed their potential applications for PDL regeneration. The review by X. Ambriz et al. focused on the mechanobiology of the actin cytoskeleton in stem cells, which is important in stem cell differentiation and interaction with biomaterials.
These studies in this special issue span a wide range, discussing the new organizational sources, biological activities, mechanobiology and proteomic profiling of MSCs. We believe that these studies have the potential to make great contributions to the research and clinical applications of MSCs.
Finally, we would like to express our deep gratitude to the reviewers for their valuable contributions to this special issue.
The editors declare that they have no conflicts of interest.
Zhongjun Li Xingbin Hu Jiang F. Zhong
Articles from Stem Cells International are provided here courtesy of Wiley
Continue reading here:
Mesenchymal Stem Cells: Characteristics, Function, and ...
- PCL scaffold with well-defined hierarchical pores effectively controls cell migration and alignment of human mesenchymal stem cells - Nature - April 4th, 2025
- Circ-ITCH promotes the ubiquitination degradation of HOXC10 to facilitate osteogenic differentiation in disuse osteoporosis through stabilizing BRCA1... - March 28th, 2025
- Injectable bioadhesive and lubricating hydrogel with polyphenol mediated single atom nanozyme for rheumatoid arthritis therapy - Nature.com - March 21st, 2025
- Nf2-FAK signaling axis is critical for cranial bone ossification and regeneration - Nature.com - March 16th, 2025
- 1. Ultimate Guide: 10 Mesenchymal Stem Cell Research Updates Now - March 14th, 2025
- The Application of Mesenchymal Stem Cell Therapy in Treating ... - Cureus - March 14th, 2025
- Innovative Study Highlights BMP9 and SHH as Key Drivers of Bone Repair - EIN News - March 14th, 2025
- Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 ... - March 11th, 2025
- Mesenchymal stem cells | EBSCO Research Starters - March 11th, 2025
- Ryoncil, the first FDA-approved mesenchymal stromal cell therapy - March 9th, 2025
- Ryoncil, the first FDA-approved mesenchymal stromal cell therapy - Pharmaceutical Technology - March 5th, 2025
- Capsanthin inhibits migration and reduces N-linked glycosylation of PD-L1 via the EZH2-PD-L1 axis in triple-negative breast cancer brain metastasis -... - March 5th, 2025
- sLZIP functions as a key modulator of bone remodeling by regulating the crosstalk between osteoblasts and osteoclasts - Nature.com - March 3rd, 2025
- Bone and muscle crosstalk in ageing and disease - Nature.com - February 27th, 2025
- Eterna Therapeutics Hosts Successful Inaugural Meeting with - GlobeNewswire - February 27th, 2025
- Mesenchymal Stem/Stromal Cells An update | SpringerLink - February 25th, 2025
- Efficacy and safety of mesenchymal stromal cell ... - PubMed - February 17th, 2025
- Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue ... - February 17th, 2025
- Mesenchymal stem cells derived exosomes: a new era in cardiac ... - February 17th, 2025
- Mesenchymal Stem Cell Therapy for Superior Gluteal Nerve ... - Cureus - February 17th, 2025
- Stem cell therapy found to reduce itch, pain in RDEB children in trial - Epidermolysis Bullosa News - February 15th, 2025
- Fate and long-lasting therapeutic effects of mesenchymal stromal/stem ... - February 6th, 2025
- Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2 - Nature.com - January 31st, 2025
- The role of ultrasound combined with water bath in the establishment of animal models of rat urethral stricture - Nature.com - January 25th, 2025
- Why exosome therapy is 2025s It skincare trend - Harpers Bazaar India - January 23rd, 2025
- Identification of glutamine as a potential therapeutic target in dry eye disease - Nature.com - January 23rd, 2025
- Polycystin-1 regulates tendon-derived mesenchymal stem cells fate and matrix organization in heterotopic ossification - Nature.com - January 21st, 2025
- Correction: Adipose-derived mesenchymal stromal cells promote corneal wound healing by accelerating the clearance of neutrophils in cornea -... - January 21st, 2025
- Adipose-Derived Stem Cell Therapy Combined With Platelet-Rich Plasma for the Treatment of Avascular Necrosis of the Talus - Cureus - January 19th, 2025
- Q&A: Mesenchymal stem cells where do they come from and is ... - January 19th, 2025
- An overview of mesenchymal stem cells and their potential ... - January 19th, 2025
- Senescent mesenchymal stem/stromal cells and restoring their cellular ... - January 13th, 2025
- Mesenchymal Stem Cells and Reticulated Platelets: New Horizons in ... - January 13th, 2025
- Mesenchymal Stem Cells/Medicinal Signaling Cells (MSCs) - GlobeNewswire - January 13th, 2025
- A SAGE View of Mesenchymal Stem Cells - PMC - January 13th, 2025
- Mesenchymal stem cell perspective: cell biology to clinical progress - January 3rd, 2025
- Canid alphaherpesvirus 1 infection alters the gene expression and secretome profile of canine adipose-derived mesenchymal stem cells in vitro -... - December 28th, 2024
- MSC-derived exosomal circMYO9B accelerates diabetic wound healing by promoting angiogenesis through the hnRNPU/CBL/KDM1A/VEGFA axis - Nature.com - December 27th, 2024
- Korean researchers prove stem cell therapys effectiveness for hereditary cerebellar ataxia in animal models - KBR - December 25th, 2024
- FDA Approves First MSC Therapy in Steroid-Refractory GVHD - www.oncnursingnews.com/ - December 25th, 2024
- FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid ... - December 22nd, 2024
- FDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in Kids - Medpage Today - December 20th, 2024
- FDA Grants First-Ever Approval for MSC Therapy to Australian Company Mesoblast After Attempting for 4 Years - geneonline - December 20th, 2024
- Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges - Benzinga - December 20th, 2024
- Mesoblast finally pushes GvHD cell therapy over finish line - pharmaphorum - December 20th, 2024
- Mesenchymal stem cells in health and disease - PubMed - December 19th, 2024
- Mesoblast's RYONCIL is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy - The Manila Times - December 19th, 2024
- FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease - PR Newswire - December 19th, 2024
- RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead - MarketWatch - December 17th, 2024
- An injury-induced mesenchymal-epithelial cell niche coordinates regenerative responses in the lung - Science - December 15th, 2024
- New insights into survival of breast cancer cells in the bone marrow - News-Medical.Net - December 9th, 2024
- Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidates (ERNA-101) Ability to Induce and Modulate... - December 7th, 2024
- Enhanced osteogenic potential of iPSC-derived mesenchymal progenitor cells following genome editing of GWAS variants in the RUNX1 gene - Nature.com - December 7th, 2024
- Exploring the potential of MSCs in cancer therapy - News-Medical.Net - December 5th, 2024
- Eterna Therapeutics Partners with MD Anderson to Advance Cancer Cell Therapy Research | ERNA Stock News - StockTitan - December 5th, 2024
- How breast cancer cells survive in bone marrow after remission - Medical Xpress - December 5th, 2024
- A blood glucose fluctuation-responsive delivery system promotes bone regeneration and the repair function of Smpd3-reprogrammed BMSC-derived exosomes... - December 1st, 2024
- Mesenchymal stromal cells alleviate depressive and anxiety-like ... - December 1st, 2024
- Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus ... - December 1st, 2024
- Exploring mesenchymal stem cells homing mechanisms and ... - PubMed - November 26th, 2024
- Macrophage tracking with USPIO imaging and T2 mapping predicts immune rejection of transplanted stem cells - Nature.com - November 26th, 2024
- IL-10RA governor the expression of IDO in the instruction of lymphocyte immunity - Nature.com - November 26th, 2024
- Mesenchymal Stem Cells: Time to Change the Name! - November 26th, 2024
- Researchers have brought the promise of stem cell therapies closer to reality - The Week - November 25th, 2024
- Engineering bone/cartilage organoids: strategy, progress, and application - Nature.com - November 25th, 2024
- Proteomic analysis of human Whartons jelly mesenchymal stem/stromal cells and human amniotic epithelial stem cells: a comparison of therapeutic... - November 20th, 2024
- Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with... - November 20th, 2024
- Mesenchymal stem cells lineage and their role in disease development - November 18th, 2024
- Mesenchymal Stem Cells - SpringerLink - November 18th, 2024
- Exosomes: The Insulin of Our Era? - University of Miami - November 18th, 2024
- Partner Perspectives: Mesenchymal Stromal Cells Could Serve as Preventive Therapy for Chronic Radiation-Induced Dry Mouth - OncLive - November 10th, 2024
- Skin-care founder Angela Caglia on the stem cell technology that created 437% sales growth: 'It's transformed the business' - Glossy - November 8th, 2024
- Substantial Overview on Mesenchymal Stem Cell Biological and Physical ... - November 8th, 2024
- Regenerative Medical Technology Group Announces the Opening of New Clinic in Dubai on November 23 - Newswire - November 8th, 2024
- BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health - StockTitan - November 8th, 2024
- Stem cell science is dominating the luxury skin-care market as human-derived ingredients become less taboo - Glossy - November 8th, 2024
- BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health - The Manila Times - November 8th, 2024
- SMART researchers develop a method to enhance effectiveness of cartilage repair therapy - MIT News - October 25th, 2024
- Biological functions of mesenchymal stem cells and clinical ... - October 24th, 2024
- Chemical-defined medium supporting the expansion of human mesenchymal ... - October 24th, 2024
Recent Comments